Dr. Sweeney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 858-657-7000Fax+1 301-581-0077
Summary
- Dr. Daniel Sweeney is a pulmonologist in San Diego, CA and is affiliated with UC San Diego Medical Center – Hillcrest. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 16 years. He specializes in critical care medicine and infectious disease and is experienced in critical care, infectious diseases, neurocritical care, point-of-care ultrasound.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Critical Care Medicine (Internal Medicine), 2004 - 2008
- Johns Hopkins UniversityFellowship, Infectious Disease, 2005 - 2007
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2001 - 2004
- University of Texas Southwestern Medical SchoolClass of 2001
Certifications & Licensure
- CA State Medical License 2010 - 2025
- MD State Medical License 2004 - 2011
- DC State Medical License 2008 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 23 citationsA ten-year-old boy with a pulmonary nodule secondary to Cryptococcus neoformans: case report and review of the literature.Daniel A. Sweeney, Mary T. Caserta, David N. Korones, Arturo Casadevall, David L. Goldman
The Pediatric Infectious Disease Journal. 2003-12-01 - 76 citationsHow to use biomarkers of infection or sepsis at the bedside: guide to clinicians.Pedro Póvoa, Luís Coelho, Felipe Dal-Pizzol, Ricard Ferrer, Angela Huttner
Intensive Care Medicine. 2023-02-01 - 9 citationsDeconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization.Jonathan Fintzi, Tyler Bonnett, Daniel A. Sweeney, Nikhil Huprikar, Anuradha Ganesan
Clinical Infectious Diseases. 2021-08-19
Journal Articles
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Victor Tapson, Daniel A Sweeney, Richard A Mularski, Alpesh N Amin, Joanne Billings, Marie-Carmelle Elie, The New England Journal of Medicine
- Remdesivir for the Treatment of Covid-19 — Final ReportAneesh K Mehta, Barry S Zingman, Andre C Kalil, Helen Y Chu, Robert W Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas F Patterson, Daniel A Sweeney, Willia..., The New England Journal of Medicine
Press Mentions
- Coronavirus Is Detectable Next to the Beds of COVID-19 Patients – but Surface Transmission Is RareJune 10th, 2021
- The Microbiome of the Critically Ill PatientSeptember 23rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: